Zoledronic acid

Also known as: Zoledronate

Active ingredient description

Zoledronic acid belongs to the class of bisphosphonates and acts primarily on bone. It is an inhibitor of osteoclastic bone resorption.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Zoledronic acid
M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA08

Medicines

Zoledronic acid is the active ingredient of these drugs:

Drug
Countries

Australia Austria Brazil Canada Cyprus

Singapore

Germany

Germany

Brazil

Brazil

Poland

Australia

Poland

Tunisia

Cyprus

Poland

Australia

United States

Germany Lithuania

Brazil

Lithuania

Ireland Poland

Brazil Singapore

Lithuania

Singapore

Hong Kong

Australia

Tunisia

Singapore

Brazil

Singapore

Singapore

Australia Austria Brazil Canada Cyprus

Poland

Singapore

Zoledronic acid is also found within below combination drugs:

ASZORA TRIO CA+D3

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
Summary of Product Characteristics (SPC)

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

6XC1PAD3KF - ZOLEDRONIC ACID

CAS registry number

118072-93-8 - zoledronic acid

SNOMED-CT

395926009 - Zoledronic acid (substance)